News
IXI has raised $36.5 million in funding to launch the world’s first autofocus glasses which can correct vision dynamically.
A startup out of Finland is taking a new look at the market for prescription eyewear. Tapping into innovations in ...
For many businesses, there's no question that agentic AI will be a game changer, unlocking the value of data that's been ...
A classic gaming laptop that delivers on the frame rate promise of Nvidia's RTX 50-series, but not on the battery life.
What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...
they manufactured 10 percent of their total output by the end of 2024 and they aim to make all of their products there by the end of this year. Whether Labubu dolls will hold onto their popularity ...
"Our presentations demonstrate how we're innovating across the manufacturing process-from improved cell isolation methods, to optimized non-viral delivery approaches for gene editing, to scalable ...
Natural products are small molecules produced naturally by any organism including primary and secondary metabolites. They include very small molecules, such as urea, and complex structures ...
DFA US Vector Equity Fund earns a High Process Pillar ... The longest-tenured manager of the fund also manages a different product rated by an analyst. Their analyst-assigned People Pillar rating ...
There are no directors' trades from iShares Global Consumer Staples ETF (IXI). Please use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities. FAQs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results